Masimo (MASI) Liabilities and Shareholders Equity (2010 - 2026)

Masimo's (MASI) quarterly Liabilities and Shareholders Equity came in at $1.6 billion in Q2 2026, down 28.36% year-on-year from $2.3 billion in Q2 2025, and down 3.31% quarter-over-quarter from $1.7 billion in Q1 2026.

Masimo (MASI) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

Masimo's Liabilities and Shareholders Equity history runs 17 years deep, the most recent figure standing at $1.6 billion for Q2 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 28.36% year-over-year to $1.6 billion in Q2 2026; TTM through Apr 2026 was $7.6 billion, a 30.63% decrease from a year earlier, with the FY2026 full-year figure at $1.7 billion, down 35.3% from the prior year.
  • Liabilities and Shareholders Equity declined to $1.6 billion in Q2 2026 per MASI's latest filing, from $1.7 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $3.2 billion in Q4 2022 and bottomed at $1.6 billion in Q2 2026.
  • The 5-year median for Liabilities and Shareholders Equity is $2.9 billion (2024), against an average of $2.6 billion.
  • Across the five-year window, Liabilities and Shareholders Equity soared 76.08% in 2022 and slumped 41.14% in 2025, its largest moves.
  • Year by year, Liabilities and Shareholders Equity stood at $3.2 billion in 2022, then fell by 5.27% to $3.0 billion in 2023, then dropped by 13.67% to $2.6 billion in 2024, then slumped by 30.78% to $1.8 billion in 2025, then slipped by 9.62% to $1.6 billion in 2026.
  • Per Business Quant, the three latest MASI Liabilities and Shareholders Equity figures stand at $1.6 billion (Q2 2026), $1.7 billion (Q1 2026), and $1.8 billion (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn 110.43 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn 46.29 Bn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn 13.32 Bn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn 6.63 Bn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn 37.13 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn - 10.46 Bn
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 31.92 Bn
10 Masimo 9.39 Bn 9.27 Bn 250.80 Mn 1.64 Bn

Historic Data

Download Data
DateValue
Apr 4, 2026 1.64 Bn
Jan 3, 2026 1.70 Bn
Sep 27, 2025 1.82 Bn
Jun 28, 2025 2.40 Bn
Mar 29, 2025 2.29 Bn
Dec 28, 2024 2.63 Bn
Sep 28, 2024 3.09 Bn
Jun 29, 2024 2.89 Bn
Mar 30, 2024 2.96 Bn
Dec 30, 2023 3.04 Bn
Sep 30, 2023 3.00 Bn
Jul 1, 2023 3.01 Bn
Apr 1, 2023 3.12 Bn
Dec 31, 2022 3.21 Bn
Oct 1, 2022 3.06 Bn
Jul 2, 2022 2.96 Bn
Apr 2, 2022 1.91 Bn
Jan 1, 2022 1.89 Bn
Oct 2, 2021 1.77 Bn
Jul 3, 2021 1.68 Bn